BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24715304)

  • 1. Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India.
    Choudhury B; Srivastava S; Choudhury HH; Purkayastha A; DuttaGupta S; Ghosh SK
    Tumour Biol; 2014 Jul; 35(7):6739-48. PubMed ID: 24715304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum lactate dehydrogenase and alkaline phosphatase in different histological grades of head and neck squamous cell carcinoma and premalignant lesions.
    Bhattacharjee A; Giri S; Roy M; Chakraborty A
    J Cancer Res Ther; 2018; 14(5):934-940. PubMed ID: 30197328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma.
    Andersson BÅ; Lewin F; Lundgren J; Nilsson M; Rutqvist LE; Löfgren S; Laytragoon-Lewin N
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):515-9. PubMed ID: 24481866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck].
    Al Kassam D; Alvarez Marcos C; Blanco I; de Los Toyos JR; Llorente JL
    Med Clin (Barc); 2007 Dec; 129(20):761-5. PubMed ID: 18093475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of L-Arginine-Arginase Metabolic Pathway Enzymes: Immunocytochemistry and mRNA Expression in Peripheral Blood and Tissue Levels in Head and Neck Squamous Cell Carcinomas in North East India.
    Srivastava S; Ghosh SK
    Asian Pac J Cancer Prev; 2015; 16(16):7031-8. PubMed ID: 26514486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum biomarkers for detection of head and neck squamous cell carcinoma.
    Mydlarz WK; Hennessey PT; Wang H; Carvalho AL; Califano JA
    Head Neck; 2016 Jan; 38(1):9-14. PubMed ID: 24995714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
    Chang PY; Kuo YB; Wu TL; Liao CT; Sun YC; Yen TC; Chan EC
    Clin Chem Lab Med; 2013 Jun; 51(6):1291-300. PubMed ID: 23154424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma.
    Gupta A; Kumar R; Sahu V; Agnihotri V; Singh AP; Bhasker S; Dey S
    Biochem Biophys Res Commun; 2015 Nov; 467(2):248-53. PubMed ID: 26435503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis.
    Chen Y; Cong R; Ji C; Ruan W
    Cancer Med; 2020 Dec; 9(24):9541-9553. PubMed ID: 33201589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.
    Yamashita T; Shimada H; Tanaka S; Araki K; Tomifuji M; Mizokami D; Tanaka N; Kamide D; Miyagawa Y; Suzuki H; Tanaka Y; Shiotani A
    Cancer Med; 2016 Mar; 5(3):415-25. PubMed ID: 26798989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prognostic biomarkers in head and neck cancer patients.
    Lin HS; Siddiq F; Talwar HS; Chen W; Voichita C; Draghici S; Jeyapalan G; Chatterjee M; Fribley A; Yoo GH; Sethi S; Kim H; Sukari A; Folbe AJ; Tainsky MA
    Laryngoscope; 2014 Aug; 124(8):1819-26. PubMed ID: 24347532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring a 'metabolic shift' after surgical resection of oral squamous cell carcinomas by serum lactate dehydrogenase.
    Grimm M; Krimmel M; Hoefert S; Kraut W; Calgéer B; Biegner T; Teriete P; Munz A; Reinert S
    J Oral Pathol Med; 2016 May; 45(5):346-55. PubMed ID: 26403591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Kalfert D; Ludvikova M; Topolcan O; Celakovsky P; Kucera R; Windrichova J; Ludvik J; Skalova K; Kulda V; Pesta M; Plzak J
    Anticancer Res; 2017 Jun; 37(6):3281-3286. PubMed ID: 28551677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.
    Payne K; Spruce R; Beggs A; Sharma N; Kong A; Martin T; Parmar S; Praveen P; Nankivell P; Mehanna H
    Head Neck; 2018 Jul; 40(7):1598-1604. PubMed ID: 29542214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker.
    Banerjee J; Pradhan R; Gupta A; Kumar R; Sahu V; Upadhyay AD; Chaterjee P; Dwivedi S; Dey S; Dey AB
    Clin Transl Oncol; 2017 May; 19(5):571-578. PubMed ID: 27815686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
    Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
    Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: the peptide marker for the prognosis of cancer.
    Gill K; Mohanti BK; Singh AK; Mishra B; Dey S
    Cancer Biomark; 2011-2012; 10(3-4):125-34. PubMed ID: 22674298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.